Comparison of macular changes according to the etiology of optic neuritis: a cross-sectional study
Author:
Corresponding Author:

Jae Ho Jung. Department of Ophthalmology, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea. jaeho.jung@snu.ac.kr; Sung-Min Kim. Department of Neurology, Seoul National University Hospital, Seoul 03080, Republic of Korea. sueh916@gmail.com

Fund Project:

Supported by the New Faculty Startup Fund of Seoul National University (Jung JH).

  • Article
  • | |
  • Metrics
  • |
  • Reference [30]
  • |
  • Related [20]
  • | | |
  • Comments
    Abstract:

    AIM: To compare the macular structure including foveal thickness among patients with optic neuritis (ON) according to the etiology and to investigate the possible correlation between structural and visual outcomes METHODS: In this retrospective cross-sectional study, the clinical data of patients with aquaporin-4 immunoglobulin G-related ON (AQP4 group, 40 eyes), myelin oligodendrocyte glycoprotein IgG-related ON (MOG group, 31 eyes), and multiple sclerosis-related ON (MS group, 24 eyes) were obtained. The retinal thickness of the foveal, parafoveal and perifoveal regions were measured. Visual acuity (VA), visual field index and mean deviation were measured as visual outcomes. RESULTS: The AQP4 group showed a significantly thinner fovea (226.4±13.4 μm) relative to the MOG (236.8±14.0 μm, P=0.015) and MS (238.9±14.3 μm, P=0.007) groups. The thickness in the parafoveal area also was thinner in the AQP4 group, though the difference in perifoveal retinal thickness was not significant. Foveal thickness was correlated with VA in the AQP4 group (coefficient ρ=-0.418, P=0.014), but not in the MOG and MS groups (P=0.218 and P=0.138, respectively). There was no significant correlation between foveal thickness and visual field test in all three groups. CONCLUSION: The significant thinning in the fovea and parafoveal areas in the AQP4 group compared to the MOG and MS groups are found. Additionally, macular changes in AQP4-ON show a significant correlation with VA. The results provide the possibility that retinal structural damage could reflect functional damage in AQP4-ON, distinct from MOG-ON and MS-ON.

    Reference
    1 Beck RW, Cleary PA, Anderson MM Jr, Keltner JL, Shults WT, Kaufman DI, Buckley EG, Corbett JJ, Kupersmith MJ, Miller NR. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med 1992;326(9):581-588.
    2 Sakata LM, Deleon-Ortega J, Sakata V, Girkin CA. Optical coherence tomography of the retina and optic nerve - a review. Clin Exp Ophthalmol 2009;37(1):90-99.
    3 Parisi V, Manni G, Spadaro M, Colacino G, Restuccia R, Marchi S, Bucci MG, Pierelli F. Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci 1999;40(11):2520-2527.
    4 Xu SC, Kardon RH, Leavitt JA, Flanagan EP, Pittock SJ, Chen JJ. Optical coherence tomography is highly sensitive in detecting prior optic neuritis. Neurology 2019;92(6):e527-e535.
    5 Andorrà M, Alba-Arbalat S, Camos-Carreras A, et al. Using acute optic neuritis trials to assess neuroprotective and remyelinating therapies in multiple sclerosis. JAMA Neurol 2020;77(2):234-244.
    6 Shi W, Zhang HT, Zuo HX, Li SY, Zheng PP, Xu QG, Cai SY, Wei SH, Li L, Peng CX. Structural-visual functional relationships detected by optical coherence tomography in varying age-cohorts’ patients with optic neuritis. Int J Ophthalmol 2022;15(6):967-974.
    7 Bsteh G, Krajnc N, Riedl K, Altmann P, Kornek B, Leutmezer F, Macher S, Mitsch C, Pruckner P, Rommer PS, Zulehner G, Pemp B, Berger T, Vienna Multiple Sclerosis Database Study Group. Retinal layer thinning after optic neuritis is associated with future relapse remission in relapsing multiple sclerosis. Neurology 2022;99(16): e1803-e1812.
    8 Zhang Y, Qiu Y, Chen L, Guo T, Xu X, Liu X, Fu Y, Liu K, Li X, Ren X, Xiao Z, Chen S, Yang H. Subclinical damage to the contralateral eye in unilateral optic neuritis: a longitudinal study. Mult Scler Relat Disord 2023;78:104923.
    9 Naismith RT, Tutlam NT, Xu J, Klawiter EC, Shepherd J, Trinkaus K, Song SK, Cross AH. Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis. Neurology 2009;72(12):1077-1082.
    10 Ratchford JN, Quigg ME, Conger A, Frohman T, Frohman E, Balcer LJ, Calabresi PA, Kerr DA. Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology 2009;73(4):302-308.
    11 Mekhasingharak N, Laowanapiban P, Siritho S, Satukijchai C, Prayoonwiwat N, Jitprapaikulsan J, Chirapapaisan N; Siriraj Neuroimmunology Research Group. Optical coherence tomography in central nervous system demyelinating diseases related optic neuritis. Int J Ophthalmol 2018;11(10):1649-1656.
    12 Zhao X, Qiu W, Zhang Y, Luo Y, Zhang X, Lu L, Yang H. A prospective case-control study comparing optical coherence tomography characteristics in neuromyelitis optica spectrum disorder- optic neuritis and idiopathic optic neuritis. BMC Ophthalmol 2018;18(1):247.
    13 Shen T, You Y, Arunachalam S, Fontes A, Liu S, Gupta V, Parratt J, Wang C, Barnett M, Barton J, Chitranshi N, Zhu L, Fraser CL, Graham SL, Klistorner A, Yiannikas C. Differing structural and functional patterns of optic nerve damage in multiple sclerosis and neuromyelitis optica spectrum disorder. Ophthalmology 2019;126(3):445-453.
    14 Filippatou AG, Mukharesh L, Saidha S, Calabresi PA, Sotirchos ES. AQP4-IgG and MOG-IgG related optic neuritis-prevalence, optical coherence tomography findings, and visual outcomes: a systematic review and meta-analysis. Front Neurol 2020;11:540156.
    15 Vicini R, Brügger D, Abegg M, Salmen A, Grabe HM. Differences in morphology and visual function of myelin oligodendrocyte glycoprotein antibody and multiple sclerosis associated optic neuritis. J Neurol 2021;268(1):276-284.
    16 Feng C, Chen Q, Zhao G, Li Z, Chen W, Sha Y, Sun X, Wang M, Tian G. Clinical characteristics of optic neuritis phenotypes in a 3-year follow-up Chinese cohort. Sci Rep 2021;11(1):14603.
    17 Lin CW, Chen WT, Lin YH, Hung K, Chen TC. Clinical characteristics and prognosis of optic neuritis in Taiwan-a hospital-based cohort study. Mult Scler Relat Disord 2023;75:104739.
    18 Jeong IH, Kim HJ, Kim NH, Jeong KS, Park CY. Subclinical primary retinal pathology in neuromyelitis optica spectrum disorder. J Neurol 2016;263(7):1343-1348.
    19 Oertel FC, Kuchling J, Zimmermann H, Chien C, Schmidt F, Knier B, Bellmann-Strobl J, Korn T, Scheel M, Klistorner A, Ruprecht K, Paul F, Brandt AU. Microstructural visual system changes in AQP4-antibody-seropositive NMOSD. Neurol Neuroimmunol Neuroinflamm 2017;4(3):e334.
    20 You Y, Zhu L, Zhang T, Shen T, Fontes A, Yiannikas C, Parratt J, Barton J, Schulz A, Gupta V, Barnett MH, Fraser CL, Gillies M, Graham SL, Klistorner A. Evidence of Müller glial dysfunction in patients with aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder. Ophthalmology 2019;126(6):801-810.
    21 Motamedi S, Oertel FC, Yadav SK, Kadas EM, Weise M, Havla J, Ringelstein M, Aktas O, Albrecht P, Ruprecht K, Bellmann-Strobl J, Zimmermann HG, Paul F, Brandt AU. Altered fovea in AQP4-IgG-seropositive neuromyelitis optica spectrum disorders. Neurol Neuroimmunol Neuroinflamm 2020;7(5):e805.
    22 Filippatou AG, Vasileiou ES, He Y, Fitzgerald KC, Kalaitzidis G, Lambe J, Mealy MA, Levy M, Liu YH, Prince JL, Mowry EM, Saidha S, Calabresi PA, Sotirchos ES. Evidence of subclinical quantitative retinal layer abnormalities in AQP4-IgG seropositive NMOSD. Mult Scler 2021;27(11):1738-1748.
    23 Roca-Fernández A, Oertel FC, Yeo T, Motamedi S, Probert F, Craner MJ, Sastre-Garriga J, Zimmermann HG, Asseyer S, Kuchling J, Bellmann-Strobl J, Ruprecht K, Leite MI, Paul F, Brandt AU, Palace J. Foveal changes in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorder are independent of optic neuritis and not overtly progressive. Eur J Neurol 2021;28(7):2280-2293.
    24 Yang J, Kim SM, Kim YJ, Cheon SY, Kim B, Jung KC, Park KS. Accuracy of the fluorescence-activated cell sorting assay for the aquaporin-4 antibody (AQP4-Ab): comparison with the commercial AQP4-Ab assay kit. PLoS One 2016;11(9):e0162900.
    25 Lee HJ, Kim B, Waters P, Woodhall M, Irani S, Ahn S, Kim SJ, Kim SM. Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies. J Neuroinflammation 2018;15(1):302.
    26 Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018;17(2):162-173.
    27 Ahn JH, Lee SG. Comparison of inferior oblique myectomy, recession, and anterior transposition in unilateral congenital superior oblique palsy. Journal of the Korean Ophthalmological Society 2010;51(1):76-80.
    28 Sotirchos ES, Saidha S, Byraiah G, Mealy MA, Ibrahim MA, Sepah YJ, Newsome SD, Ratchford JN, Frohman EM, Balcer LJ, Crainiceanu CM, Nguyen QD, Levy M, Calabresi PA. In vivo identification of morphologic retinal abnormalities in neuromyelitis optica. Neurology 2013;80(15):1406-1414.
    29 Fard MA, Golizadeh A, Yadegari S, Ghahvehchian H, Subramanian P, Ritch R. Photoreceptor outer nuclear layer thickness changes in optic neuritis follow up. Mult Scler Relat Disord 2020;39:101905.
    30 McIlwaine G, Csincsik L, Coey R, Wang L, Fitzgerald D, Moffat J, Dubis AM, McDonnell G, Hughes S, Peto T, Lengyel I. Reduced cone density is associated with multiple sclerosis. Ophthalmol Sci 2023;3(3):100308.
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

Yeji Moon, Sung-Min Kim, Jae Ho Jung. ,/et al.Comparison of macular changes according to the etiology of optic neuritis: a cross-sectional study. Int J Ophthalmol, 2024,17(4):686-692

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History
  • Received:September 04,2023
  • Revised:November 17,2023
  • Online: March 26,2024